Clinical trial Recruiting at 1 site Observational Ages 65 to 99

Understanding the causes of sarcopenic obesity in older adults

Official title: Dissecting the Molecular and Cellular Pathophysiology of Sarcopenic Obesity in the Elderly

Run by IRCCS San Raffaele · NCT06320158 · Data updated 2026-11-12

This study looks at how obesity and loss of muscle in older adults are connected and what causes this problem, focusing on people who are having hip surgery and healthy seniors.

More Sarcopenic Obesity trials

Quick facts

Study typeObservational
Ages65 Years to 99 Years
SexAll
Enrollment1108 (estimated)
SponsorIRCCS San Raffaele
Academic / other
Locations1 site (Milan)
StatusRecruiting
StartedMay 22, 2023
Main results expectedNovember 30, 2025
Study endsDecember 31, 2025
Registry record updatedJune 18, 2025
Trial IDNCT06320158 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include elderly individuals aged 65 and older who are candidates for hip surgery or healthy older adults with specific BMI criteria.

Probably not a fit

Patients with inflammatory or neurological myopathies, acute heart failure, or active cancer may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the molecular and cellular mechanisms behind sarcopenic obesity, a condition affecting the elderly characterized by the coexistence of obesity and reduced muscle mass. By evaluating patients who are candidates for hip surgery and healthy older adults, the study seeks to uncover how increased fat mass and decreased muscle tissue contribute to this growing public health issue. The research will focus on the interplay between chronic inflammation, hormonal changes, and metabolic alterations in skeletal muscle. Through clinical evaluations, the study hopes to provide insights into the pathophysiology of sarcopenic obesity.

Why it matters

Potential benefit: If successful, this study could lead to better understanding and management strategies for sarcopenic obesity, improving health outcomes for elderly patients.

How similar studies have gone: While the specific molecular mechanisms of sarcopenic obesity are not extensively studied, related research on obesity and sarcopenia has shown promising results in understanding these conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

patients who are candidates for hip surgery

* patients who are candidates for hip surgery
* age ≥ 65 years
* patients able to give consent

healthy subjects

\- healthy subjects from the geriatric cohort studied in 2016-2017 who at that time were: were overweight (25 ≤ BMI \< 30 kg/m2) or obese (BMI ≥ 30 kg/m2) but had not yet developed sarcopenia

Exclusion Criteria:

All partecipants

* unavailability to participate in the study
* inflammatory or neurological myopathies
* acute heart failure
* active cancer

Where it's running

  • Ospedale San Raffaele
    Milan, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.